12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Defibrotide regulatory update

Gentium plans to submit a response this quarter to Day 120 questions from EMA's CHMP related to the review of an MAA for defibrotide to treat and prevent hepatic veno-occlusive disease (VOD) in...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >